论文部分内容阅读
目的:探讨分析三氧化二砷序贯TD(沙利度胺+地塞米松)治疗复发性骨髓瘤与其他二线方案对比的临床疗效。方法:回顾分析我科48例复发MM病例,随机分为亚砷酸组和对照组,分析2组的总有效率。结论:三氧化二砷序贯TD(沙利度胺+地塞米松)治疗复发性难治性骨髓瘤的临床疗效可靠,经济条件要求不高,患者易接受。
Objective: To investigate the clinical efficacy of sequential arsenic trioxide (TD) (thalidomide + dexamethasone) in the treatment of recurrent myeloma compared with other second-line regimens. Methods: Retrospective analysis of 48 cases of recurrent MM in our department, were randomly divided into arsenious acid group and control group, analysis of the total efficiency of the two groups. Conclusion: Arsenic trioxide sequential TD (thalidomide + dexamethasone) for the treatment of recurrent refractory myeloma clinical efficacy of reliable, less demanding economic conditions, the patient is easy to accept.